Facing Death With Psychedelics

One gram of psilocybin, the psychoactive ingredient in hallucinogenic mushrooms, is seen on a scale at New York University in New York. (AP Photo/Seth Wenig)
We all hope we’d be filled with grace and serenity when facing death at the end of a long struggle with a terminal illness. But for many, it is a moment of anxiety, fear and potential psychological trauma. Now, science is turning its interest back to the potential healing power of psychedelic drugs to alleviate end-of-life anxiety.
“The thinking is that with the aid of the psychedelic… it may help bring back memories; it promotes introspection, it can be a touchstone, it can be grounding,” said Dr. John Halpern, a researcher who has used MDMA – also known as ecsatasy – to help relieve end-of-life stresses in two cancer patients.
We’ll talk with Dr. Halpern about the state of the science of psychedelics, and what it says over all about how Americans approach end-of-life care.
Guest:
- Dr. John Halpern, head of the Laboratory for Integrative Psychiatry at McLean Hospital
More:
- New York Times: How Psychedelic Drugs Can Help Patients Face Death
- Radio Boston: Mother Goes To Extremes To Prevent Daughter’s End Of Life Suffering
Other stories from this show:
-
Call_Me_Missouri
-
Call_Me_Missouri
-
http://www.facebook.com/StevenGarson Steve Garson
-
Kate
Hosts Meghna Chakrabarti and Anthony Brooks introduce us to newsmakers, big thinkers and artists and bring us stories of relevance to Bostonians here and around the region. Live every weekday at 3.
- Listen: Weekdays, 3 p.m. on 90.9 FM
- Live Call-In: (800) 423-TALK
- Listener Voicemail: (617) 358-0607



